Ranbaxy Laboratories, country’s largest drug maker and Daiichi Sankyo has step up community initiative in India with the flag-off of two free Mobile Rural Healthcare Service Vans for District Dewas in Madhya Pradesh. This is the first CSR programme being undertaken jointly by the two companies as part of their commitment towards global social contribution activities.
This initiative will be implemented through Ranbaxy Community Healthcare Society (RCHS), a non profit organization established by Ranbaxy. RCHS is already running mobile healthcare services in district Dewas. The two new Mobile healthcare service vans extend the reach and further reinforce and strengthen the medical services being provided in the region.
Recently, the company received conditional market approval from the country's drug regulator for its anti-malaria drug. The company is likely to launch country's first privately-developed medicine and ending more than a decade of failures.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1863.90 |
| Dr. Reddys Lab | 1279.75 |
| Cipla | 1338.65 |
| Zydus Lifesciences | 935.55 |
| Lupin | 2250.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: